Join NAMSA as we discuss the future of at-home diagnostic testing with our panel of infectious disease experts. Our team will draw on their experience working for or with infectious disease industry leaders to pack up the following boxes:

• Box 1: Looking at our past, would past pandemics have benefited from at home tests? What have we learned from COVID-19 that could be applied to this move?
• Box 2: What must be packed up to support the “Big Move?” User environment, testing accuracy, pivotal trial design and global regulatory requirements (at a minimum) must to be considered.
• Box 3: Should Infectious Disease Diagnostics move out of the care setting and into the home, just because it can? Our panel will discuss the pros and cons of the big move